Targeted sequencing of a large number of genes associated with hematologic malignancies revealed rare and potentially deleterious NSD1 mutations in AML patients suggesting that not only gain but also loss of NSD1 can contribute to transformation of hematopoietic cells [60]. This evidence concerns the gene NSD1 and acute myeloid leukemia.